Talis Biomedical Overview

Talis Biomedical EBIT

EBIT (Earnings Before Interest and Taxes) analysis for TLIS.

Quarterly EBIT

-$8.58M

↑ 47.67% YoY

As of Jun 30, 2024

Annual EBIT (TTM)

-$49.20M

↑ 45.51% YoY

Trailing 12 months ending Jun 30, 2024

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin